Literature DB >> 20500676

Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats.

A Gruden-Movsesijan1, N Ilic, M Mostarica-Stojkovic, S Stosic-Grujicic, M Milic, L Sofronic-Milosavljevic.   

Abstract

Trichinella spiralis is a helminth that provokes Th2 and anti-inflammatory type responses in an infected host. Our previous studies using Dark Agouti (DA) rats indicated that T. spiralis infection reduced experimental autoimmune encephalomyelitis (EAE) severity in rats. The aim of this study was to analyse the mechanisms underlying EAE suppression driven by T. spiralis infection. Reduced clinical and histological manifestations of the disease were accompanied by increased IL-4 and IL-10 production and decreased IFN-gamma and IL-17 production in draining lymph node cells. This indicates that T. spiralis infection successfully maintains a Th2 cytokine bias regardless of EAE induction. High IL-10 signifies parasite-induced anti-inflammatory and/or regulatory cell responses. Transfer of splenic T cell-enriched population of cells from T. spiralis-infected rats into EAE immunized rats caused amelioration of EAE and in some cases protection from disease development. This population of cells contained higher proportion of CD4(+) CD25(+) Foxp3(+) regulatory cells and produced high level of IL-10 when compared with uninfected rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20500676     DOI: 10.1111/j.1365-3024.2010.01207.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  41 in total

1.  Immunomodulatory effects of Trichinella spiralis-derived excretory-secretory antigens.

Authors:  Ivana Radovic; Alisa Gruden-Movsesijan; Natasa Ilic; Jelena Cvetkovic; Slavko Mojsilovic; Marija Devic; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 2.  Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Avijit Ray; Sreemanti Basu; Christopher L Karp; Bonnie N Dittel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

Review 3.  Trichinella spiralis: shaping the immune response.

Authors:  Natasa Ilic; Alisa Gruden-Movsesijan; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 4.  Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders.

Authors:  Amir Abdoli; Hoda Mirzaian Ardakani
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

Review 5.  Helminth-host immunological interactions: prevention and control of immune-mediated diseases.

Authors:  David E Elliott; Joel V Weinstock
Journal:  Ann N Y Acad Sci       Date:  2012-01-12       Impact factor: 5.691

Review 6.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 7.  Gut commensalism, cytokines, and central nervous system demyelination.

Authors:  Kiel Telesford; Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

8.  Helminth infections decrease host susceptibility to immune-mediated diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

9.  Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis.

Authors:  L J Sofronic-Milosavljevic; I Radovic; N Ilic; I Majstorovic; J Cvetkovic; A Gruden-Movsesijan
Journal:  Med Microbiol Immunol       Date:  2013-01-11       Impact factor: 3.402

10.  Helminths: Immunoregulation and Inflammatory Diseases-Which Side Are Trichinella spp. and Toxocara spp. on?

Authors:  Carmen Aranzamendi; Ljiljana Sofronic-Milosavljevic; Elena Pinelli
Journal:  J Parasitol Res       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.